Kontafarma China Holdings Ltd

01312

Company Profile

  • Business description

    Kontafarma China Holdings Ltd is principally engaged in the manufacture and sale of prescription drugs including chemical drugs active pharmaceutical ingredients and API intermediates in the PRC, operating of fitness centres and provision of consultation services for fitness and health activities and operating of the franchise business for royalty fee income. The operating segments include the pharmaceutical business and the Fitness business. The majority of its revenue derives from the pharmaceutical business segment.

  • Contact

    30 Harbour Road
    Room 12A 09-20, 12th Floor, Sun Hung Kai Centre
    Wanchai
    Hong Kong
    HKG

    T: +852 27316500

    http://www.kontafarma.com.hk

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    688

Stocks News & Analysis

stocks

Netflix: A business that’s nearly flawless

Streaming giant’s stellar results had areas of softness; currency tailwinds drive guidance raise.
stocks

Trump’s US dollar assault is fuelling CBA’s rise

A recent $1 billion investment in CBA by Texas based fund manager expresses concern for the outlook of the USD.
stocks

Insignia Financial: Revised deal still attractive

The offer price is well above our fair value.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,979.4022.00-0.24%
CAC 407,818.2832.15-0.41%
DAX 4024,295.9355.110.23%
Dow JONES (US)44,849.59160.70-0.36%
FTSE 1009,138.3776.880.85%
HKSE25,667.18129.110.51%
NASDAQ21,077.5557.530.27%
Nikkei 22541,826.34655.021.59%
NZX 50 Index12,805.1311.070.09%
S&P 5006,375.3416.430.26%
S&P/ASX 2008,709.4027.80-0.32%
SSE Composite Index3,605.7323.430.65%

Market Movers